2024-05-14T16:16:03-05:00 2023-06-30 BDO USA 200 PARK AVENUE 38TH FLOOR NEW YORK NY 10166 990 2022-07-01 954335088 Lymphoma Research Foundation % THE ORGANIZATION LYMP 2123492910 WALL ST PLAZA 88 PINE ST STE 2400 NEW YORK NY 10005 MEGHAN GUTIERREZ CEO 2123492910 2024-05-14 true MEGHAN GUTIERREZ 999009999 Paul Hammerschmidt P01384178 2128858000 2024-05-14 2 2022 2023-04-26 12:10:37Z MEGHAN GUTIERREZ WALL ST PLAZA 88 PINE ST STE 2400 NEW YORK NY 10005 24530498 false X WWW.LYMPHOMA.ORG X 2001 NY TO ERADICATE LYMPHOMA AND SERVE THOSE TOUCHED BY THIS DISEASE. 17 17 38 20000 0 0 9913811 12020634 4596956 4214232 154465 312830 44695 19260 14709927 16566956 5760500 5530100 0 0 3571099 4043590 0 0 2168038 3569296 4381905 12900895 13955595 1809032 2611361 35546178 41061805 7990127 10723212 27556051 30338593 X THE LYMPHOMA RESEARCH FOUNDATION'S (LRF) MISSION IS TO ERADICATE LYMPHOMA AND SERVE THOSE TOUCHED BY THIS DISEASE. LRF IS DEDICATED TO IDENTIFYING A CURE THROUGH AN INNOVATIVE RESEARCH PROGRAM AND TO HELPING MEMBERS OF THE LYMPHOMA COMMUNITY BY PROVIDING COMPREHENSIVE, DISEASE-SPECIFIC PROGRAMS AND SUPPORT SERVICES. LRF INVESTS MILLIONS OF DOLLARS EVERY YEAR TO COMBAT LYMPHOMA AND ASSIST THOSE WHOSE LIVES HAVE BEEN AFFECTED BY A LYMPHOMA DIAGNOSIS. LRF IS SUPPORTED BY MORE THAN 20,000 VOLUNTEERS WHO CONTRIBUTE THEIR TIME AND TALENTS TO FURTHER THE LRF MISSION AND SERVE THEIR LOCAL COMMUNITIES. LRF HAS EARNED THE TRUST OF INDIVIDUALS, PRIVATE FOUNDATIONS, PUBLIC COMPANIES, AND ORGANIZATIONS THAT FUND ITS WORK BY DEMONSTRATING A HISTORY OF CAREFUL AND PROVEN FINANCIAL STEWARDSHIP. false false 6193925 5495000 0 RESEARCH AND PATIENT AID - THE FOUNDATION IS COMMITTED TO FUNDING THE MOST ADVANCE PATIENT CARE AND IMPROVE PATIENT OUTCOMES. THROUGH ITS LYMPHOMA CONSORTIA, RESEARCH INITIATIVES, AND SCIENTIFIC WORKSHOPS, LRF MOBILIZES THE RESEARCH COMMUNITY TO SPEED THE DEVELOPMENT AND USE OF NEW TREATMENTS. 3060144 35100 4214232 EDUCATIONAL PROGRAMS AND PATIENT SERVICES - LRF PROVIDES A COMPREHENSIVE SERIES OF PROGRAMS AND SERVICES FOR THE LYMPHOMA COMMUNITY INCLUDING, BUT NOT LIMITED TO, CONTINUING MEDICAL EDUCATION, CLINICAL TRIALS INFORMATION SERVICES, DISEASE SPECIFIC PUBLICATIONS AND WEBSITES, IN-PERSON PATIENT WORKSHOPS AND EDUCATIONAL FORUMS, LYMPHOMA HELPLINE, ONLINE SERVICES, PATIENT AID GRANTS, TELECONFERENCES AND WEBCASTS/PODCASTS, WITH A VOLUNTEER COMMUNITY NETWORK. 1157029 0 0 COMMUNICATIONS AND ADVOCACY - THROUGH STRATEGIC COMMUNICATIONS, LRF SEEKS TO RAISE AWARENESS OF LYMPHOMA AND THE NEEDS OF PEOPLE WITH LYMPHOMA. DIGITAL PROGRAMMING ENSURES ACCESS TO ACCURATE INFORMATION AND DIGITAL PROGRAMS INCLUDING MOBILE APPS. LRF'S ADVOCACY PROGRAM ENABLES VOLUNTEERS TO REPRESENT THE NEEDS OF PEOPLE WITH LYMPHOMA BY SUPPORTING PUBLIC POLICIES WHICH SEEK TO INCREASE FEDERAL FUNDING FOR LYMPHOMA RESEARCH AND ENSURE ACCESS TO HIGH QUALITY CANCER CARE. 10411098 true true false true false false false false false true false false false true true false true false false true true false false true false false true true true false false false false false false false false true false false false false true true false false false true 38 0 true 38 true false false false false false true true false false false false false false X 17 17 false false false false false false false true true false false true true true true true true true false false AL AR CA FL GA HI IL KS KY MD MA MI MN MS MO NV NH NJ NM NY NC OR PA RI SC TN UT VA WV WI X X X THE ORGANIZATION 2123492910 WALL ST PLAZA 88 PINE STE 2400 NEW YORK NY 10005 X MEGHAN GUTIERREZ CHIEF EXECUTIVE OFFICER 35.0 0.0 X 320781 0 16159 LAURA WALLENSTEIN CHIEF PHILANTHROPY OFFICER 35.0 0.0 X 215228 0 21801 CAROLINA FLORES THRU 4272023 SENIOR DIRECTOR OF FINANCE 35.0 0.0 X 173415 0 39370 SARAH QUINLAN see sch o CHIEF PROGRAM OFF/SR DIR PROG. 35.0 0.0 X 167113 0 19516 MICAH BANNER SENIOR DIRECTOR, IND. GIVING 35.0 0.0 X 149065 0 7965 VICTOR GONZALEZ SENIOR DIRECTOR, PATIENT PRG. 35.0 0.0 X 127215 0 17416 KATHRYN LEBOEUF THRU 52023 DIRECTOR, MAJ.& PLANNED GIVING 35.0 0.0 X 115670 0 6720 NICHOLE MUSUMECI ASSOCIATE DIR, EXTERNAL COMM. 35.0 0.0 X 101000 0 15214 STEVEN EICHBERG BOARD CHAIR 2.0 0.0 X X 0 0 0 JEFF BLOCK VICE CHAIR AND TREASURER 2.0 0.0 X X 0 0 0 KIM METCALF VICE CHAIR 2.0 0.0 X X 0 0 0 LEIGH OLSON SECRETARY 2.0 0.0 X X 0 0 0 MICHAEL AKINYELE BOARD MEMBER 1.0 0.0 X 0 0 0 MICHAEL FROY BOARD MEMBER 1.0 0.0 X 0 0 0 HARRIET GREENBERG BOARD MEMBER 1.0 0.0 X 0 0 0 ROBERT MCCAULEY BOARD MEMBER 1.0 0.0 X 0 0 0 JOHN A NELSON BOARD MEMBER 1.0 0.0 X 0 0 0 SCOTT PANSKY BOARD MEMBER 1.0 0.0 X 0 0 0 DIANE PARKS BOARD MEMBER 1.0 0.0 X 0 0 0 JOEL POLLICK BOARD MEMBER 1.0 0.0 X 0 0 0 KEVIN SHEA BOARD MEMBER 1.0 0.0 X 0 0 0 JOHN P LEONARD MD PAST CHAIR, SCIENTIFIC ADVISOR 1.0 0.0 X 0 0 0 STEVEN J PRINCE PAST CHAIR, BOARD MEMBER 1.0 0.0 X 0 0 0 SONALI M SMITH MD CHAIR, SCIENTIFC ADVISORY BOAR 1.0 0.0 X 0 0 0 MICHAEL WERNER IMMEDIATE PAST CHAIR 1.0 0.0 X 0 0 0 Paul Belanger CONTRACTED CFO EFF. 4/28/2023 35.0 0.0 X 0 0 0 1369487 0 144161 8 false true false ALLISON PARTNERS LLC ONE WORLD TRADE CENTER 69TH FLOOR NEW YORK NY 10007 PUBLIC RELATIONS 318783 Med Communications Inc 5100 Poplar Ave Ste 450 MEMPHIS TN 38137 medical affairs 251361 Build Consulting LLC PO Box 223444 CHANTILLY VA 201533444 IT ConsultinG 215733 Parkel Navigation Group LLC 174 Mountain Road RIDGEFIELD CT 06877 research & insight 108200 4 2163923 9856711 123811 12020634 EDUCATION PROGRAMS & PATIENT SERVICES 812900 4214232 4214232 4214232 312785 0 312785 0 9876 9876 0 0 0 7803363 7803318 45 45 45 160224 2163923 160224 0 0 0 0 0 0 0 MISCELLANEOUS REVENUE 900099 9384 9384 9384 16566956 4214232 0 332090 4745000 4745000 35100 35100 750000 750000 0 978132 522555 139181 316396 0 2227586 1205339 300911 721336 76735 34711 17523 24501 431501 195190 98537 137774 329636 149111 75275 105250 0 11221 11221 68525 68525 0 0 0 1115377 750771 283309 81297 639431 614316 7834 17281 479052 248951 71879 158222 59329 49364 9965 0 407238 277085 46347 83806 314292 224951 6241 83100 0 1265366 901769 47097 316500 0 0 43265 36156 7109 37498 17300 20198 DUES AND SUBSCRIPTIONS 303341 150137 113783 39421 PROCESSING FEES 201873 83876 39909 78088 LICENSES AND PERMITS 13786 8720 5066 REPAIRS AND MAINTENANCE 2895 2895 -580584 -580584 13955595 10411098 1376459 2168038 9111263 12237893 23159618 23767395 2730505 3222919 159721 0 0 0 0 0 0 0 0 0 285347 276411 195658 135668 99724 59990 0 0 0 0 0 0 0 0 0 1497197 35546178 41061805 1052864 490081 6741890 8551640 195373 125000 0 0 0 0 0 0 0 0 0 0 0 1556491 7990127 10723212 X 5715532 4979089 21840519 25359504 27556051 30338593 35546178 41061805 2611361 171181 X false true X true false X 7623538 9778478 10361473 9913811 12020634 49697934 0 0 7623538 9778478 10361473 9913811 12020634 49697934 15940691 33757243 227922 312354 234178 176115 322661 1273230 0 14788 2356 39700 22100 9384 88328 51059492 0.66114 0.69180 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED false true false false false true 30000 false true 171872 201872 false SCHEDULE C, PART II-B, LINE 1: CONTACT WITH LEGISLATORS, THEIR STAFF, GOVERNMENT OFFICIALS, LEGISLATIVE BODIES, AND ASSOCIATED GRASSROOTS ACTIVITIES TO PRESENT ISSUES OF CONCERN RELATED TO LYMPHOMA. 113640 70557 43083 61685 50199 11486 20333 14912 5421 59990 0 OPERATING LEASE LIABILITY 1556491 1556491 X 17506737 171181 768600 939781 16566956 16566956 14724195 768600 768600 13955595 13955595 SCHEDULE D, PART X, LINE 2: THE FOUNDATION FOLLOWS GAAP, WHICH REQUIRES ACCOUNTING FOR UNCERTAINTY IN TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN, INCLUDING ISSUES RELATING TO FINANCIAL STATEMENT RECOGNITION AND MEASUREMENT. U.S. GAAP PROVIDES THAT THE TAX EFFECTS FROM AN UNCERTAIN TAX POSITION CAN ONLY BE RECOGNIZED IN THE CONSOLIDATED FINANCIAL STATEMENTS IF THE POSITION IS MORE LIKELY THAN NOT TO BE SUSTAINED IF THE POSITION WERE TO BE CHALLENGED BY A TAXING AUTHORITY. THE ASSESSMENT OF THE TAX POSITION IS BASED SOLELY ON THE TECHNICAL MERITS OF THE POSITION, WITHOUT REGARD TO THE LIKELIHOOD THAT THE TAX POSITION MAY BE CHALLENGED. THE FOUNDATION IS INCORPORATED IN THE STATE OF NEW YORK AND IS EXEMPT FROM FEDERAL INCOME TAX UNDER IRC SECTION 501(C)(3), THOUGH IT IS SUBJECT TO TAX ON INCOME UNRELATED TO ITS EXEMPT PURPOSE, UNLESS THAT INCOME IS OTHERWISE EXCLUDED BY THE IRC. THE ORGANIZATION HAS NO UNRELATED INCOME ASSOCIATED WITH ITS EXEMPT PURPOSE. THE FOUNDATION HAS PROCESSES PRESENTLY IN PLACE TO ENSURE THE MAINTENANCE OF ITS TAX-EXEMPT STATUS, TO IDENTIFY AND REPORT UNRELATED INCOME, TO DETERMINE ITS FILING AND TAX OBLIGATIONS IN JURISDICTIONS FOR WHICH NEXUS WAS ESTABLISHED, AND TO IDENTIFY AND EVALUATE OTHER MATTERS THAT MAY BE CONSIDERED TAX POSITIONS. THE FOUNDATION HAS DETERMINED THAT THERE ARE NO MATERIAL UNCERTAIN TAX POSITIONS THAT REQUIRE RECOGNITION OR DISCLOSURE IN THE CONSOLIDATED FINANCIAL STATEMENTS. AS OF JUNE 30, 2023, THE FOUNDATION WAS NOT SUBJECT TO AN EXAMINATION BY A TAXING AUTHORITY. true North America Grantmaking 750000 750000 750000 North America FOLLICULAR 750000 wire 2 false false false false false false ANNUAL GALA 745254 632157 113097 113097 WALKS, BIKE 776216 776216 3 802677 755550 47127 47127 2324147 2163923 160224 160224 160224 true Icahn School of Medicine at Mount Sinai PO Box 3500 New York NY 100296574 136171197 501(c)(3) 750000 FOLLICULAR MAYO CLINIC ROCHESTER MN PO Box 860334 Minneapolis MN 554860334 416011702 501(c)(3) 975000 FOLLICULAR Weill Medical College of Cornell University PO Box 22371 New York NY 10087 131623978 855000 FOLLICULAR Stanford University PO BOX 884253 Los Angeles CA 90088 941156365 501(c)(3) 750000 FOLLICULAR Memorial Sloan Kettering Cancer Center 1275 York Avenue New York NY 10065 131924236 501(c)(3) 235000 CDA & MENTORING Northwestern Univ Feinberg School of Medicine 633 Clark Street Evanston IL 602081112 362167817 501(c)(3) 225000 CDA The Trustees of the University of Pennsylvania PO Box 785541 Philadelphia PA 191785541 231352685 501(c)(3) 330000 CDA & FELLOWSHIP Dana-Farber Cancer Institute 450 Brookline Ave Boston MA 022155450 042263040 501(c)(3) 125000 FELLOWSHIP & MENTORING The Trustees of Columbia Univ in the City of NY PO Box 29789 New York NY 10087 121000248 501(c)(3) 105000 FELLOWSHIP Brigham and Women's Hospital Inc PO Box 3149 Boston MA 022413149 042312909 501(c)(3) 105000 FELLOWSHIP Univ of Texas MD Anderson Cancer Center PO Box 4266 Houston TX 772104266 746001118 501(c)(3) 125000 FELLOWSHIP & MENTORING Beckman Research Institute of the City of Hope 1500 East Duarte Road Duarte CA 91010 953432210 501(c)(3) 105000 FELLOWSHIP Columbia University Medical Center PO Box 29789 New York NY 10087 135598093 501(c)(3) 10000 MENTORING City of Hope Comprehensive Cancer Center 1500 East Duarte road Duarte CA 91010 953435919 501(c)(3) 10000 MENTORING The Ohio State Univ College of Medicine 1960 Kenny Road Columbus OH 43210 316025986 501(c)(3) 10000 MENTORING Augusta University Research Institute Inc PO Box 945552 Atlanta GA 30394 581418202 501(c)(3) 10000 MENTORING The University of Utah 201 S Presidents Salt Lake City UT 84112 876000525 501(c)(3) 10000 MENTORING Massachusetts General Hospital (Mass General) PO Box 414876 Boston MA 02241 042697983 501(c)(3) 10000 MENTORING 17 1 Patient Aid Grant 351 35100 PART I, LINE 2: LRF'S EXPERT SCIENTIFIC ADVISORY BOARD (SAB) CONDUCTS PEER REVIEW FOR ALL GRANT PROPOSALS AND RECOMMENDS THE HIGHEST-SCORING PROPOSALS TO THE LRF BOARD OF DIRECTORS FOR FUNDING. THE BOARD OF DIRECTORS THEN CONSIDERS AND APPROVES THE GRANTS WHICH ARE TO BE FUNDED. ONCE A GRANT IS APPROVED AND ACCEPTED BY THE GRANTEE, THE GRANTEE WILL BEGIN TO RECEIVE INSTALLMENTS BASED UPON THE PAYMENT SCHEDULE AS DICTATED IN THE GRANT CONTRACT. THE SAB AND LRF'S RESEARCH DEPARTMENT ANNUALLY REVIEW EACH GRANTEE'S PROGRESS AGAINST DELIVERABLES AND APPROVES THE CONTINUATION OF GRANT PAYMENTS. PART III, LINE 1: LRF PROVIDES FINANCIAL ASSISTANCE TO LYMPHOMA PATIENTS WHO STRUGGLE TO PAY FOR EXPENSES RELATED TO THEIR LYMPHOMA TREATMENTS, SUCH AS MEDICAL BILLS AND TRANSPORTATION COSTS. LRF SUPPORT SERVICES STAFF REVIEWS THE APPLICATIONS, VALIDATES APPLICATION CRITERIA AND SUBMITS APPLICATIONS FOR PAYMENT APPROVAL TO DEPARTMENT LEADERSHIP. X X X false false false false false false false true false MEGHAN GUTIERREZ CHIEF EXECUTIVE OFFICER 280781 0 40000 0 0 0 16039 0 120 0 336940 0 0 0 CAROLINA FLORES THRU 4272023 SENIOR DIRECTOR OF FINANCE 173415 0 0 0 0 0 8671 0 30699 0 212785 0 0 0 SARAH QUINLAN see sch o CHIEF PROGRAM OFF/SR DIR PROG. 167113 0 0 0 0 0 8356 0 11160 0 186629 0 0 0 MICAH BANNER SENIOR DIRECTOR, IND. GIVING 149065 0 0 0 0 0 7453 0 512 0 157030 0 0 0 LAURA WALLENSTEIN CHIEF PHILANTHROPY OFFICER 215228 0 0 0 0 0 10761 0 11040 0 237029 0 0 0 PART I, LINE 7: SCHEDULE J, PART II, COLUMN (B)(II) REPORTS DISCRETIONARY INCENTIVE AMOUNTS THAT WERE APPROVED BY THE BOARD BASED UPON PERFORMANCE. X 10 123811 MARKET QUOTATION false true false SCHEDULE M, PART I, COLUMN B: NUMERICAL DATA HERE REPRESENTS THE TOTAL NUMBER OF CONTRIBUTIONS RECEIVED. FORM 990, PART VI, SECTION B, LINE 11B: FORM 990 WAS PREPARED BY A NATIONAL ACCOUNTING FIRM IN CONJUNCTION WITH THE ORGANIZATION'S FINANCIAL DEPARTMENT. THE FORM 990 WAS REVIEWED IN DETAIL BY MANAGEMENT. AFTER REVIEW A FINAL DRAFT WAS PRESENTED TO THE AUDIT COMMITTEE AND FULL BOARD OF DIRECTORS FOR REVIEW AND COMMENT PRIOR TO FILING WITH THE INTERNAL REVENUE SERVICE. FORM 990, PART VI, SECTION B, LINE 12C: THE CONFLICT OF INTEREST POLICY IS REVIEWED AND SIGNED ANNUALLY BY BOARD MEMBERS, OFFICERS AND STAFF. FORM 990, PART VI, SECTION B, LINE 15A: THE ORGANIZATION SETS COMPENSATION IN A MANNER GIVING RISE TO A REBUTTABLE PRESUMPTION THAT THE COMPENSATION IS REASONABLE UNDER STANDARDS SET FORTH IN TREASURY REGULATIONS SECTION 53.4958-6. SALARIES OF THE SENIOR STAFF, INCLUDING THE CEO, ARE DETERMINED BASED UPON MARKET INFORMATION COMPARABLE TO THE POSITION IN OTHER NON-PROFIT ORGANIZATIONS. THE CEO'S COMPENSATION IS APPROVED BY THE EXECUTIVE COMMITTEE (EC), WHICH HAS BEEN DULY AUTHORIZED BY THE BOARD AND CONSISTS OF INDEPENDENT MEMBERS, AND THE APPROVAL IS DOCUMENTED CONTEMPORANEOUSLY IN THE EC MINUTES. FORM 990, PART VI, SECTION C, LINE 19: THE ORGANIZATION'S GOVERNING DOCUMENTS, FINANCIAL STATEMENTS AND THE CONFLICT OF INTEREST POLICY ARE AVAILABLE TO THE PUBLIC UPON REQUEST. THE ORGANIZATION ALSO MAKES ITS FINANCIAL STATEMENTS AVAILABLE THEIR WEBSITE. FORM 990, PART VII, SECTION A, LINE : COMPENSATION REPORTED ON PART VII FOR Sarah Quinlan IS FOR HER POSITION AS Senior Director, Program THRU JULY 10, 2022 AND CHIEF PROGRAM OFFICER EFFECTIVE JULY 11, 2022. LRF RESEARCH INC WALL ST PLAZA 88 PINE ST STE 24 NEW YORK NY 10005 611844536 INVESTMENT FUND NY LRF C CORP 0 0 1.00000 true false false false false false false false false false false false false false false false false false false false